These gene-specific alterations may explain the development of characteristic phenotypes such as acromesomelic dysplasia in the patient, while genome-wide changes indicate global deleterious consequences of DDX41 deficiency. The gene discussed is DDX41; the disease is acromesomelic dysplasia.